Showing results (51-60 of 177) with videos related to

Sort By:
Pageof 18
JAMA Oncology|October 18, 2019
Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide Therapy vs Other Donor Transplantations in Adults With Hematologic Cancers: A Systematic Review and Meta-analysisNico Gagelmann, Andrea Bacigalupo, Alessandro Rambaldi, et al.
Bone Marrow Transplantation|March 31, 2023
Spleen volume and length determined by computed tomography impact outcome after allogeneic stem cell transplantation for myelofibrosisMarlene Luther, Frank Oliver Henes, Tatjana Zabelina, et al.
Transplantation and Cellular Therapy|September 25, 2025
Remission Status Prior to Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia/Myelodysplastic Syndrome Patients Harboring Single-Hit or Multi-Hit p53 Mutations Does Not Impact OutcomeNormann Steiner, Evgeny Klyuchnikov, Anita Badbaran, et al.
Cancers|May 28, 2020
Can <sup>18</sup>F-NaF PET/CT before Autologous Stem Cell Transplantation Predict Survival in Multiple Myeloma?Christos Sachpekidis, Annette Kopp-Schneider, Maximilian Merz, et al.
Neurochemical Research|July 17, 2016
Genetic Susceptibility to Bortezomib-Induced Peripheral Neuroropathy: Replication of the Reported Candidate Susceptibility LociChiara Campo, Miguel Inacio Da Silva Filho, Niels Weinhold, et al.
The Plant Journal : for Cell and Molecular Biology|May 25, 2019
Glucosylation of the phytoalexin N-feruloyl tyramine modulates the levels of pathogen-responsive metabolites in Nicotiana benthamianaGuangxin Sun, Michael Strebl, Maximilian Merz, et al.
Blood Cancer Discovery|October 23, 2024
Bispecific Antibodies as Bridging to BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple MyelomaDavid Fandrei, Sabine Seiffert, Michael Rade, et al.
Journal of Hematology & Oncology|May 21, 2026
Standard-of-care ciltacabtagene autoleucel in earlier versus later lines of therapy for relapsed or refractory multiple myeloma: a nationwide registry analysisNico Gagelmann, Hermann Einsele, Sarah Flossdorf, et al.
Transplantation and Cellular Therapy|October 17, 2024
Sequential Conditioning With FLAMSA Does Not Improve Outcomes of Allogeneic Stem Cell Transplantation in Chronic Myelomonocytic Leukemia PatientsRadwan Massoud, Evgeny Klyuchnikov, Normann Steiner, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 21, 2024
Consistency of Spleen and Symptom Reduction Regardless of Cytopenia in Patients With Myelofibrosis Treated With PacritinibNico Gagelmann, Prithviraj Bose, Vikas Gupta, et al.
Pageof 18